Site Overlay

Editorial

I.E.Cock1,2*
1Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.
2School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.

Pharmacognosy Communications,2018,8,3,96
DOI: 10.5530/pc.2018.3.20.
Published: July 2018
Type: Editorial

ABSTRACT

Dear Readers and Authors, I am pleased to bring you volume 8, issue 3 of Pharmacognosy Communications. In this issue we present new research examining the pharmacognosy of several important medicinal plants including the antibacterial and antifungal activity of the Asia medicinal plant Ajuga bracteosa. This species is used in a diverse array of Asian traditional medicine systems (including traditional Chinese medicine and Ayuverda) to treat a variety of inflammatory conditions including gout, rheumatism and amenorrhea. It has also been used for treatment of diabetes, malaria, and cancer. We also present a pharmacognostic study on Delonix regia. This species has an impressive range of medicinal and biological properties including uses for the treatment of constipation, inflammation, arthritis, hemiplagia, gynecological disorders, diabetes and rheumatism. An Indonesian study examined the phytochemistry of Myristica fragrans mace extracts and reported good antioxidant and antibacterial activity. Furthermore, the extracts inhibited α-glucosidase, indicating that they may also be useful in the treatment of diabetes. A further study examines the antioxidant properties of Mangifera indica leaves. We also present study which used an in silico docking model to highlight some phytochemicals with potential COX-2 and LOX-3 inhibitory potential. In particular, gallic acid and epicatechin were determined to be promising leads. Read more…

Copyright © 2021 Pharmacognosy Communications. All Rights Reserved. | Catch Sketch by Catch Themes
Scroll Up